These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Developmental changes in gamma-glutamyl transpeptidase in human amniotic fluid.
    Author: Jalanko H.
    Journal: Oncodev Biol Med; 1983; 4(4):253-9. PubMed ID: 6132362.
    Abstract:
    Human amniotic fluid gamma-glutamyl transpeptidase (GGT) occurs in a high molecular weight form, as shown by G-200 gel chromatography. Papain treatment causes the formation of a GGT molecule with an approximate molecular weight of 98 000. Early amniotic fluid contains GGT which binds mostly to Con A-Sepharose and shows alpha-mobility on cellulose acetate electrophoresis. In late amniotic fluid, the major portion of the GGT activity is concanavalin A-nonreactive and is present in the beta-region on electrophoresis. Neuraminidase treatment abolishes the difference in the electrophoretic mobility between early and late amniotic fluid GGT. Papain treatment has no effect on the electrophoretic mobility or concanavalin A-binding of GGT. The results suggest that the carbohydrate moiety of amniotic fluid GGT undergoes developmental changes during gestation.
    [Abstract] [Full Text] [Related] [New Search]